Senloytics, dasatinib plus quercetin, reduce kidney inflammation, senescent cell abundance, and injury while restoring geroprotective factors in murine diabetic kidney disease
- Authors:
- Xiaohui Bian
- Zachary K. Snow
- Caroline J. Zinn
- Anastasia L. Bratulin
- Khaled M. Elhusseiny
- Tamar Tchkonia
- James L. Kirkland
- Yi Zhu
- Sundeep Khosla
- Seo Rin Kim
- Lilach O. Lerman
- LaTonya J. Hickson
- Reference:
- eBioMedicine
- 2026
- 124
- 106124
- DOI:
- 10.1016/j.ebiom.2026.106124